Hydrus Microstent vs Goniotomy during cataract surgery
Part of Eyes & vision clinical trials.
This study compares two procedures done during cataract surgery: placing a tiny stent (Hydrus Microstent) or performing a goniotomy (a small cut in the eye's drainage tissue). Both aim to lower eye pressure in people with mild to moderate open-angle glaucoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cataract that needs surgery and you have mild to moderate open-angle glaucoma.
- Your eye pressure while on medication must be between 10 and 31 mmHg.
- You have not had any previous glaucoma laser treatments or glaucoma surgery.
- You are not taking blood thinners (except a daily low-dose aspirin of 81 mg).
- You have not used oral steroids in the last 90 days and do not expect to need them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different devices (MINIject® and Hydrus® Microstent) used in microinvasive glaucoma surgery, both done at the same time as cataract surgery. It aims to find which one works better at lowering eye pressure.
This study looks at whether two types of tiny drainage stents (PreserFlo and XEN) work safely to lower eye pressure in glaucoma. Some patients will also receive an amniotic membrane (a thin tissue that helps healing) during the surgery, and researchers will compare outcomes.
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
This study compares a glaucoma drainage device approach to see which one better prevents loss of corneal cells after surgery. You may benefit by receiving close monitoring around the time of glaucoma surgery and helping doctors improve surgical choices.
This trial tests a small stent to help drain fluid from the eye and lower pressure in people who have both open-angle glaucoma and cataracts. The stent is placed during routine cataract surgery.
This study enrolls people who have cataracts and primary open-angle glaucoma that is being treated with eye drops. It will look at how well the Hydrus microstent works after approval, especially for lowering eye pressure safely.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.